156 related articles for article (PubMed ID: 33826922)
1. Endogenous opioid and cannabinoid systems modulate the muscle pain: A pharmacological study into the peripheral site.
Gonçalves WA; Ferreira RCM; Rezende BM; Mahecha GAB; Gualdron M; de Macedo FHP; Duarte IDG; Perez AC; Machado FS; Cruz JS; Romero TRL
Eur J Pharmacol; 2021 Jun; 901():174089. PubMed ID: 33826922
[TBL] [Abstract][Full Text] [Related]
2. Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence.
Aguiar DD; Gonzaga ACR; Teófilo ALH; Miranda FA; Perez AC; Duarte IDG; Romero TRL
Life Sci; 2022 Mar; 293():120279. PubMed ID: 35032552
[TBL] [Abstract][Full Text] [Related]
3. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of opioid and cannabinoid systems in the peripheral antinociception mediated by resveratrol.
Oliveira CDC; Castor MGME; Castor CGME; Costa ÁF; Ferreira RCM; Silva JFD; Pelaez JMN; Capettini LDSA; Lemos VS; Duarte IDG; Perez AC; Santos SHS; Romero TRL
Toxicol Appl Pharmacol; 2019 Apr; 369():30-38. PubMed ID: 30763598
[TBL] [Abstract][Full Text] [Related]
5. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
6. Dipyrone is locally hydrolyzed to 4-methylaminoantipyrine and its antihyperalgesic effect depends on CB
Gonçalves Dos Santos G; Vieira WF; Vendramini PH; Bassani da Silva B; Fernandes Magalhães S; Tambeli CH; Parada CA
Eur J Pharmacol; 2020 May; 874():173005. PubMed ID: 32057719
[TBL] [Abstract][Full Text] [Related]
7. Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans.
van Dorp EL; Kest B; Kowalczyk WJ; Morariu AM; Waxman AR; Arout CA; Dahan A; Sarton EY
Anesthesiology; 2009 Jun; 110(6):1356-63. PubMed ID: 19461298
[TBL] [Abstract][Full Text] [Related]
8. Noradrenaline induces peripheral antinociception by endogenous opioid release.
Romero TRL; Soares Santos RR; Castor MGME; Petrocchi JA; Guzzo LS; Klein A; Duarte IDG
Pharmacol Rep; 2018 Aug; 70(4):784-788. PubMed ID: 29940509
[TBL] [Abstract][Full Text] [Related]
9. Peltatoside Isolated from Annona crassiflora Induces Peripheral Antinociception by Activation of the Cannabinoid System.
Oliveira CD; Veloso CC; Ferreira RC; Lage GA; Pimenta LP; Duarte ID; Romero TR; Perez AC
Planta Med; 2017 Feb; 83(3-04):261-267. PubMed ID: 27574895
[TBL] [Abstract][Full Text] [Related]
10. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.
Pacheco Dda F; Klein A; Perez AC; Pacheco CM; de Francischi JN; Reis GM; Duarte ID
Br J Pharmacol; 2009 Sep; 158(1):225-31. PubMed ID: 19594755
[TBL] [Abstract][Full Text] [Related]
11. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
12. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
Kalra A; Urban MO; Sluka KA
J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
[TBL] [Abstract][Full Text] [Related]
13. Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors.
Pacheco Dda F; Romero TR; Duarte ID
Brain Res; 2014 May; 1562():69-75. PubMed ID: 24675031
[TBL] [Abstract][Full Text] [Related]
14. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
15. The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.
Ghosh S; Wise LE; Chen Y; Gujjar R; Mahadevan A; Cravatt BF; Lichtman AH
Life Sci; 2013 Mar; 92(8-9):498-505. PubMed ID: 22749865
[TBL] [Abstract][Full Text] [Related]
16. Peripheral mu-, kappa- and delta-opioid receptors mediate the hypoalgesic effect of celecoxib in a rat model of thermal hyperalgesia.
Correa JD; Paiva-Lima P; Rezende RM; Dos Reis WG; Ferreira-Alves DL; Bakhle YS; Francischi JN
Life Sci; 2010 Jun; 86(25-26):951-6. PubMed ID: 20451533
[TBL] [Abstract][Full Text] [Related]
17. Involvement of peripheral opioid receptors in electroacupuncture analgesia for carrageenan-induced hyperalgesia.
Taguchi R; Taguchi T; Kitakoji H
Brain Res; 2010 Oct; 1355():97-103. PubMed ID: 20707990
[TBL] [Abstract][Full Text] [Related]
18. Involvement of opioid receptors in oxytocin-induced antinociception in the nucleus accumbens of rats.
Gu XL; Yu LC
J Pain; 2007 Jan; 8(1):85-90. PubMed ID: 17097925
[TBL] [Abstract][Full Text] [Related]
19. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
[TBL] [Abstract][Full Text] [Related]
20. α
Romero TRL; Miranda E Castor MG; Parrella C; Piscitelli F; Di Marzo V; Duarte IDG
Pharmacol Rep; 2020 Feb; 72(1):96-103. PubMed ID: 32016857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
